| Financial Year |
March 31 2023 |
| Monetary Funds |
1,433,384,275.00 |
| Held-for-trading Financial Assets |
348,286,300.94 |
| Notes Receivable |
43,031,849.07 |
| Accounts Receivable |
1,577,618,272.91 |
| Advances to Suppliers |
201,530,073.87 |
| Other Receivables |
16,117,741.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,088,380,880.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
119,520,194.16 |
| Total Current Assets |
4,900,564,876.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
624,597.60 |
| Long-term Equity Investment |
453,067,233.95 |
| Investment Properties |
580,545,772.39 |
| Fixed Assetes |
2,605,641,415.40 |
| Under-construction Projects |
22,840,722.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
167,426,917.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,175,792.70 |
| Deferred Income Tax Assets |
83,057,153.65 |
| Other Non-Current Assets |
18,422,256.57 |
| Sub-Total of Non-Current Assets |
4,066,303,072.18 |
| Total Assets |
8,966,867,948.98 |
| Short-Term Loans |
2,483,838,712.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
388,028,728.55 |
| Accounts Payable |
1,818,917,331.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
87,585,467.17 |
| Taxes Payable |
43,991,356.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,682,454.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
463,436,265.60 |
| Other Current Liabilities |
11,897,367.45 |
| Sub-Total of Current Liabilities |
5,469,167,757.02 |
| Long-term Loans |
190,720,645.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
17,991,055.79 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
76,759,079.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
368,205,461.98 |
| Total Liabilities |
5,837,373,219.00 |
| Paid-In Capital(Or Share Stock) |
917,129,784.00 |
| Capital Surplus |
642,996,581.83 |
| Surplus Reserve |
155,801,785.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,226,744,876.89 |
| Minority Stockholder's Interest |
9,497,407.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,119,997,322.56 |
| Owner's Equity（Stockholder's Equity） |
3,129,494,729.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,966,867,948.98 |
